Gunnar Wagenius
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Surgery
- Cancer Research top 10%
- Co-authors
- Daniel BrattströmPatrik HesseliusMichael BergqvistOla BrodinMats LambeStefan BergströmJohan HanssonAnders Larsson
- Topics
- Lung Cancer Treatments and Mutations (30 papers)Lung Cancer Research Studies (17 papers)Lung Cancer Diagnosis and Treatment (16 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Gunnar Wagenius
77 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 94
- Oncology 873
- Pulmonary and Respiratory Medicine 600
- Molecular Biology 417
- Surgery 196
- Cancer Research 164
Countries citing papers authored by Gunnar Wagenius
This map shows the geographic impact of Gunnar Wagenius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gunnar Wagenius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gunnar Wagenius more than expected).
Fields of papers citing papers by Gunnar Wagenius
This network shows the impact of papers produced by Gunnar Wagenius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gunnar Wagenius. The network helps show where Gunnar Wagenius may publish in the future.
Co-authorship network of co-authors of Gunnar Wagenius
This figure shows the co-authorship network connecting the top 25 collaborators of Gunnar Wagenius. A scholar is included among the top collaborators of Gunnar Wagenius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gunnar Wagenius. Gunnar Wagenius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 3 | |
| 5 | 21 | |
| 6 | 33 | |
| 7 | 10 | |
| 8 | 61 | |
| 9 | Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: a phase II study from the Swedish Lung Cancer Study Group | 1 |
| 10 | 23 | |
| 11 | 45 | |
| 12 | 11 | |
| 13 | 6 | |
| 14 | 15 | |
| 15 | 83 | |
| 16 | 29 | |
| 17 | 18 | |
| 18 | 14 | |
| 19 | Basic fibroblast growth factor and vascular fibroblast growth factor measured in sera from patients with non-small cell lung cancer. | 3 |
| 20 | 91 |
About Gunnar Wagenius
Gunnar Wagenius is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology and Allergy, having authored 80 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (30 papers), Lung Cancer Research Studies (17 papers) and Lung Cancer Diagnosis and Treatment (16 papers). The work is most often cited by research in Oncology (873 citations), Pulmonary and Respiratory Medicine (600 citations) and Cancer Research (164 citations). Gunnar Wagenius has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Daniel Brattström, Patrik Hesselius, Michael Bergqvist, Ola Brodin, Mats Lambe, Stefan Bergström, Johan Hansson, Anders Larsson, Kristina Lamberg and Ulrika Stierner. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.